Ofev
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.ofev.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ofev
The U.S. Food and Drug Administration (FDA) approved Ofev for the treatment of idiopathic pulmonary fibrosis (IPF) on October 15, 2014. Ofev is one of the first FDA-approved drug treatments for IPF and the only kinase inhibitor approved to treat this disease. The approval was based on findings from a robust clinical trial program involving more than 1,200 patients with IPF worldwide, and included the Phase II TOMORROW trial and the Phase III INPULSIS® trials (INPULSIS-1 and INPULSIS-2. All these studies were randomized, double-blind, placebo-controlled trials comparing Ofev 150 mg twice daily to placebo for 52 weeks. Both INPULSIS trials were identically designed while the TOMORROW study design was similar.Explore more
Popular SearchesOfevSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ofev your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ofev had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ofev has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Ofev launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ofev
Check out if Ofev is spiking on competitors!
Funding: Get notified immidiatlly once Ofev has new funding data
Earning: See what the market has to say on Ofev recently announced quarterly report
Ofev, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Ofev
Find more new buyers
Compare Similar Companies to Ofev
Compare insights from companies similar to Ofev, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ofev
$7.3M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Ofev is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ofev is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ofev.
Ofev Tech Stack
A closer look at the technologies used by Ofev
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ofev
Sign Up For FreeTo access detailed company insights
The U.S. Food and Drug Administration (FDA) approved Ofev for the treatment of idiopathic pulmonary fibrosis (IPF) on October 15, 2014. Ofev is one of the first FDA-approved drug treatments for IPF and the only kinase inhibitor approved to treat this disease. The approval was based on findings from a robust clinical trial program involving more tha... Read More
